Skip to content
Clinical Trials – home

Oxazepam: A Comprehensive Guide for Patients

4 / 6
trials open to patients / all trials
5+
Countries

In short

Oxazepam, a benzodiazepine medication, has been the subject of several clinical trials investigating its potential uses and effects in various medical conditions. These trials have explored oxazepam's role in treating alcohol withdrawal syndrome, cocaine addiction, and its interactions with other medications. Researchers have also examined its safety profile and pharmacokinetics in different patient populations, including those with HIV infections and gerontopsychiatric patients.

At a glance

Conditions Studied
Alcohol withdrawal syndrome, cocaine addiction, tobacco use disorder, HIV infections
Study Designs
Randomized, double-blind, placebo-controlled, comparative studies
Comparators
Placebo, gamma-hydroxybutyric acid (GHB), combination with metyrapone
Primary Outcomes
Reduction in withdrawal symptoms, drug craving, safety and tolerability
Secondary Outcomes
Pharmacokinetics, cognitive function, quality of life, sleep quality
Safety Assessments
Adverse events, physical examinations, vital signs, ECG, laboratory tests
Special Populations
HIV-infected patients, gerontopsychiatric patients, tobacco smokers
Drug Interactions
With zidovudine (AZT), metyrapone

What is Oxazepam?

Oxazepam is a medication that belongs to a class of drugs called benzodiazepines. It is also known by the brand name Serax. Benzodiazepines are among the most frequently prescribed classes of drugs and are commonly used for patients with chronic diseases.

This medication works by affecting certain chemicals in the brain to produce a calming effect. It is primarily used to treat anxiety disorders and manage symptoms of alcohol withdrawal.

Medical Uses

Oxazepam is prescribed for several medical conditions, including:

  • Anxiety Disorders: It helps reduce feelings of anxiety and nervousness.
  • Alcohol Withdrawal Syndrome: Oxazepam is used to manage symptoms that occur when a person stops drinking alcohol after long-term or heavy use.
  • Insomnia: In some cases, it may be prescribed to help with sleep problems.

How Oxazepam Works

Oxazepam works by enhancing the effects of a natural chemical in the body called gamma-aminobutyric acid (GABA). GABA is a neurotransmitter that helps to calm the brain and nervous system. By increasing GABA's effects, oxazepam produces a sedative and anxiety-reducing effect.

Dosage and Administration

The dosage of oxazepam can vary depending on the condition being treated and the individual patient's needs. Here are some general guidelines based on the studies reviewed:

  • For Alcohol Withdrawal Syndrome: A typical dosage might be 60mg three times daily for the first few days, gradually reducing over a period of about 10 days.
  • For Anxiety: Dosages can range from 10mg to 30mg, taken two to four times daily.

It's important to note that these are just examples, and your doctor will prescribe the appropriate dosage for your specific situation. Always follow your doctor's instructions and never adjust your dosage without consulting them first.

Side Effects and Safety

Like all medications, oxazepam can cause side effects. Common side effects may include:

  • Drowsiness or sleepiness
  • Dizziness
  • Confusion
  • Headache
  • Nausea

In some cases, more serious side effects can occur. These may include changes in mood or behavior, memory problems, or signs of an allergic reaction. If you experience any severe or unusual symptoms, contact your healthcare provider immediately.

It's important to note that oxazepam can be habit-forming, especially when used for long periods or in high doses. Your doctor will carefully monitor your use of this medication.

Drug Interactions

Oxazepam can interact with other medications, potentially altering their effects or increasing the risk of side effects. Some notable interactions include:

  • Zidovudine (AZT): A study investigated the potential interaction between oxazepam and zidovudine, an HIV medication. This research highlights the importance of monitoring for potential interactions in patients taking multiple medications.
  • Other Central Nervous System Depressants: Combining oxazepam with other medications that cause drowsiness or slow breathing can increase these effects. This includes alcohol, other benzodiazepines, and certain pain medications.

Always inform your healthcare provider about all medications, supplements, and herbal products you are taking to avoid potential interactions.

Current Research and Studies

Oxazepam continues to be the subject of various research studies:

  • Alcohol Withdrawal Treatment: A study compared the effectiveness of oxazepam to gamma-hydroxybutyrate (GHB) in treating alcohol withdrawal syndrome. This research aims to find the most effective treatments for this condition.
  • Combination Therapy for Addiction: Researchers are investigating the potential of combining oxazepam with other medications, such as metyrapone, for treating cocaine and tobacco addiction.
  • Safety in Elderly Patients: A study is examining the safety of various psychotropic medications, including oxazepam, in elderly psychiatric patients. This research is crucial for understanding how these medications affect older adults.

These ongoing studies demonstrate the continued interest in understanding and improving the use of oxazepam in various medical contexts.

Questions people often ask

Conditions where Oxazepam is being studied

Each condition opens its own overview and trial list

Trials with Oxazepam

Recruiting trials first

See all 6 →
Quick filters
  • Participants:Adults
  • Participants:Adults · Healthy volunteers
  • Participants:Adults · Healthy volunteers
  • Participants:Adults · Healthy volunteers
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).